BioSpace
MARCH 7, 2021
The Russian government is attempting to cast a negative light on the COVID-19 vaccine developed by Pfizer and BioNTech, as well as other vaccines, in order to boost sales of its own vaccine, Sputnik V, the government charged.
Scienmag
MARCH 7, 2021
Free mobile app demystifies glaucoma – helping to explain symptoms, impact and treatment to patients and their families Credit: Allergan Researchers from City, University London, supported by Allergan Pharmaceuticals and Glaucoma UK, have today released the latest edition of an app to help people newly diagnosed with glaucoma. The launch coincides with World Glaucoma Week […].
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
BioSpace
MARCH 7, 2021
As of yet, the findings from the late-stage trial have not been published, but CytoDyn said it is preparing a manuscript of the study data to submit to one or more major journals.
JAMA Internal Medicine
MARCH 7, 2021
This analysis pools data from 4 large cohort studies conducted in 58 countries to assess whether associations of fish consumption with risk of cardiovascular disease or mortality differ between individuals with and individuals without vascular disease.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
BioSpace
MARCH 7, 2021
Microbiome company Seres Therapeutics announced the discontinuation of its Phase Ib trial of SER-401, an orally delivered consortia of bacteria that was intended to boost the efficacy of checkpoint inhibitors in patients with metastatic melanoma.
Scienmag
MARCH 7, 2021
Virtual reality avatar-based coaching shows promise to increase access to and extend the reach of nutrition education programs to children at risk for obesity, according to the Journal of Nutrition Education and Behavior Credit: Journal of Nutrition Education and Behavior Philadelphia, March 8, 2021 – Virtual reality avatar-based coaching shows promise to increase access to […].
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Scienmag
MARCH 7, 2021
Series authors issue a call to action for fast-tracked funding to improve program coverage and quality service delivery which have been adversely affected by the COVID-19 crisis Credit: International Center for Equity in Health The Lancet today published the latest Series on Maternal and Child Undernutrition Progress, including three new papers that build upon findings […].
BioSpace
MARCH 7, 2021
Roche announced it was voluntarily withdrawing the U.S. indication Tecentriq for in prior-platinum treated metastatic urothelial carcinoma (mUC) after failing to meet endpoints in confirmatory trials.
Drug Patent Watch
MARCH 7, 2021
Annual Drug Patent Expirations for ENJUVIA Enjuvia is a drug marketed by Aspen and is included in one NDA. There are two patents protecting this drug. This drug has seventeen…. The post New patent expiration for ASPEN drug ENJUVIA appeared first on DrugPatentWatch - Make Better Decisions.
BioSpace
MARCH 7, 2021
It was another busy week for clinical trial announcements. Here’s a look.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
JAMA Internal Medicine
MARCH 7, 2021
Fish and shellfish (hereafter referred to as fish) are major sources of the dietary long-chain ?-3 fatty acids eicosapentaenoic acid (20:5n-3) and docosahexaenoic acid (22:6n-3) and also contain other nutrients, such as vitamin D, riboflavin, iodine, calcium, phosphorus, magnesium, potassium, zinc, and iron. The summed results of observational studies of fish intake, randomized clinical trials of fish oil supplements, and associated mechanistic and experimental studies suggest that regular fish
BioSpace
MARCH 7, 2021
Merck and Ridgeback Biotherapeutics announced preliminary results from Ridgeback’s Phase IIa trial of molnupiravir in COVID-19.
Scienmag
MARCH 7, 2021
Youth with child welfare involvement are at an elevated risk for suicide but may benefit from suicide prevention interventions targeting health care settings and family-preservation Suicide is the second leading cause of death among youth aged 5 to 21 years in the United States. Between 2010 and 2019, suicide rates among this group increased 40%. […].
BioSpace
MARCH 7, 2021
AnaptysBio started the week with some disappointing news for its lead antibody drug imsidolimab.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Scienmag
MARCH 7, 2021
For the drug approval process in the United States, investigators have been expanding clinical trials to sites outside the country. However, a new study indicates that this trend may be widening racial disparities in patient enrollment in cancer clinical trials. The study is published by Wiley early online in CANCER, a peer-reviewed journal of the […].
BioTech 365
MARCH 7, 2021
Lee’s Pharmaceutical Announces its Anti-PD-L1 Antibody Socazolimab, Licensed From Sorrento Therapeutics, Receives Clearance to Start Phase 3 Trial as a First-line Treatment of Extensive-stage Small-Cell Lung Cancer Lee’s Pharmaceutical Announces its Anti-PD-L1 Antibody Socazolimab, Licensed From Sorrento Therapeutics, Receives Clearance … Continue reading →
Scienmag
MARCH 7, 2021
Bill & Melinda Gates Medical Research Institute to develop formulation -AGREEMENT ADVANCES EVOLUTION OF SYNTHETIC LUNG SURFACTANTS TO TREAT RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS IN LOW- AND MIDDLE-INCOME COUNTRIES- LOS ANGELES (March 8, 2021) — The Lundquist Institute (TLI) and The Bill & Melinda Gates Medical Research Institute (Gates MRI) executed a license agreement […].
BioTech 365
MARCH 7, 2021
Genentech Provides Update on Tecentriq U.S. Indication in Prior-Platinum Treated Metastatic Bladder Cancer Genentech Provides Update on Tecentriq U.S. Indication in Prior-Platinum Treated Metastatic Bladder Cancer SOUTH SAN FRANCISCO, Calif.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Scienmag
MARCH 7, 2021
Wearing a protective face mask has only a modest effect on the ability of healthy people to do vigorous exercise, according to a study published today (Monday) in the European Respiratory Journal [1]. Researchers carried out detailed testing on breathing, heart activity and exercise performance in a group of 12 people while they were using […].
BioTech 365
MARCH 7, 2021
Vifor Pharma and Cara Therapeutics announce U.S. FDA acceptance and Priority Review of NDA for KORSUVA™* injection in hemodialysis patients with moderate-to-severe pruritus Vifor Pharma and Cara Therapeutics announce U.S.
Drug Patent Watch
MARCH 7, 2021
This chart shows the pharmaceutical companies with the most patents in European Patent Office. Patents must be filed in each country (or, in some cases regional patent office) where patent…. The post Which pharmaceutical companies have the most drug patents in European Patent Office? appeared first on DrugPatentWatch - Make Better Decisions.
BioTech 365
MARCH 7, 2021
Masimo Monitoring Solutions Promote Newborn and Maternal Safety Masimo Monitoring Solutions Promote Newborn and Maternal Safety New Neonatal Study Adds to Body of Clinical Evidence Demonstrating Masimo SET® Pulse Oximetry’s Unique Ability to Improve Care NEUCHATEL, Switzerland–(BUSINESS WIRE)–Masimo (NASDAQ: MASI) … Continue reading →
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Scienmag
MARCH 7, 2021
Drug approved by the US Food and Drug Administration now shown ineffective – participants preferred a placebo An independent analysis of the medical trials which formed the final basis of approval by the US Food and Drug Administration (FDA) strongly suggests the drug bremelanotide has very limited effectiveness as a treatment for hypoactive sexual desire […].
BioTech 365
MARCH 7, 2021
LSK Global PS Adopts Veeva Vault Clinical Applications to Streamline Global Trial Processes LSK Global PS Adopts Veeva Vault Clinical Applications to Streamline Global Trial Processes Leading Korean CRO using Vault eTMF, Vault CTMS, and Veeva SiteVault Free for increased … Continue reading →
Expert insights. Personalized for you.
107 
Let's personalize your content